Hi Rennis, agree and TU 4 U. I approach LRF as a trading stock for these reasons. They have just re-commenced the buyback so perhaps NTA gap closure to 30% again on cards.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%